Seminars in Hematology
Volume 44, Supplement 2 , Pages S17-S30, April 2007

Role of Imatinib-Sensitive Tyrosine Kinases in the Pathogenesis of Chronic Myeloproliferative Disorders

  • Daniel J. DeAngelo

      Affiliations

    • Corresponding Author InformationAddress correspondence to Daniel J. DeAngelo, MD, PhD, Assistant Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115.

Department of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(07)00022-4

doi:10.1053/j.seminhematol.2007.02.001

Seminars in Hematology
Volume 44, Supplement 2 , Pages S17-S30, April 2007

Article Tools

* Image Usage & Resolution